Skip to main content
Fig. 3 | Diagnostic Pathology

Fig. 3

From: Development of crizotinib-associated renal cyst in a non-small cell lung cancer patient with ALK fusion: a case report and review of the literature

Fig. 3

Serial contrast-enhanced abdominal CT scan after discontinuation of crizotinib. Panels A-D: One month after stopping crizotinib treatment, showing significant reduction of the size of cystic lesions. Panels E-H: Two months after stopping crizotinib treatment, showing continuous reduction of the cystic lesions. Panels I-L: Six months after stopping crizotinib treatment, demonstrating size of renal cysts significantly decreased and hepatic cyst nearly disappeared

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us